Aurobindo Pharma unit launches ADQUEY ointment in US

Aurobindo Pharma's biopharmaceutical arm, Acrotech Biopharma Inc., has launched ADQUEY (difamilast 1%) ointment in the United States. The ointment is indicated for the treatment of mild-to-moderate atopic dermatitis in adults and pediatric patients aged 2 years and older.